BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16620275)

  • 1. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria.
    Harzallah F; Alberti H; Ben Khalifa F
    Diabet Med; 2006 Apr; 23(4):441-4. PubMed ID: 16620275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study.
    Yoon YS; Lee ES; Park C; Lee S; Oh SW
    Int J Obes (Lond); 2007 Mar; 31(3):528-34. PubMed ID: 16865099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
    Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
    Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
    Nilsson PM; Engström G; Hedblad B
    Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions.
    Zabetian A; Hadaegh F; Azizi F
    Diabetes Res Clin Pract; 2007 Aug; 77(2):251-7. PubMed ID: 17234299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
    Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
    BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of the metabolic syndrome among Korean adults using the new International Diabetes Federation definition and the new abdominal obesity criteria for the Korean people.
    Kim HM; Kim DJ; Jung IH; Park C; Park J
    Diabetes Res Clin Pract; 2007 Jul; 77(1):99-106. PubMed ID: 17118477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis.
    Panagiotakos DB; Pitsavos C; Das UN; Skoumas Y; Stefanadis C
    Diabetes Obes Metab; 2007 Sep; 9(5):660-8. PubMed ID: 17697058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the new international diabetes federation definition of metabolic syndrome to WHO and NCEP definitions in Chinese, European and South Asian origin adults.
    Unwin N; Bhopal R; Hayes L; White M; Patel S; Ragoobirsingh D; Alberti G
    Ethn Dis; 2007; 17(3):522-8. PubMed ID: 17985508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: a report of a national survey.
    Malik M; Razig SA
    Metab Syndr Relat Disord; 2008 Sep; 6(3):177-86. PubMed ID: 18699721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population.
    Császár A; Kékes E; Abel T; Papp R; Kiss I; Balogh S
    Blood Press; 2006; 15(2):101-6. PubMed ID: 16754273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study.
    Mattsson N; Rönnemaa T; Juonala M; Viikari JS; Raitakari OT
    J Intern Med; 2007 Feb; 261(2):159-69. PubMed ID: 17241181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.